News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,118 Results
Type
Article (86657)
Company Profile (703)
Press Release (762756)
Multimedia
Podcasts (136)
Webinars (17)
Section
Business (232748)
Career Advice (4129)
Deals (39738)
Drug Delivery (129)
Drug Development (91036)
Employer Resources (198)
FDA (18141)
Job Trends (17349)
News (396628)
Policy (39779)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (99)
Alliances (56912)
ALS (111)
Alzheimer's disease (1531)
Antibody-drug conjugate (ADC) (179)
Approvals (18089)
Artificial intelligence (360)
Autoimmune disease (33)
Automation (18)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (123)
Biotechnology (481)
Bladder cancer (92)
Brain cancer (36)
Breast cancer (366)
Cancer (2820)
Cardiovascular disease (227)
Career advice (3536)
Career pathing (34)
CAR-T (196)
Cell therapy (540)
Cervical cancer (22)
Clinical research (73880)
Collaboration (1001)
Company closure (3)
Compensation (617)
Complete response letters (30)
COVID-19 (2892)
CRISPR (58)
C-suite (304)
Cystic fibrosis (114)
Data (2742)
Decentralized trials (2)
Denatured (47)
Depression (62)
Diabetes (321)
Diagnostics (6952)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (162)
Drug pricing (145)
Drug shortages (35)
Duchenne muscular dystrophy (115)
Earnings (97400)
Editorial (47)
Employer branding (25)
Employer resources (168)
Events (131043)
Executive appointments (862)
FDA (19698)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (910)
Gene editing (135)
Generative AI (36)
Gene therapy (402)
GLP-1 (882)
Government (5199)
Grass and pollen (6)
Guidances (179)
Healthcare (20907)
Huntington's disease (28)
IgA nephropathy (36)
Immunology and inflammation (167)
Immuno-oncology (6)
Indications (34)
Infectious disease (3063)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (63)
Intellectual property (112)
Interviews (813)
IPO (17875)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (51)
Layoffs (576)
Leadership (25)
Legal (10125)
Liver cancer (82)
Lung cancer (401)
Lymphoma (187)
Machine learning (9)
Management (65)
Manufacturing (398)
MASH (90)
Medical device (14677)
Medtech (14682)
Mergers & acquisitions (22510)
Metabolic disorders (860)
Multiple sclerosis (99)
NASH (23)
Neurodegenerative disease (129)
Neuropsychiatric disorders (37)
Neuroscience (2214)
NextGen: Class of 2025 (7686)
Non-profit (5087)
Now hiring (44)
Obesity (455)
Opinion (283)
Ovarian cancer (95)
Pain (108)
Pancreatic cancer (105)
Parkinson's disease (181)
Partnered (25)
Patents (282)
Patient recruitment (136)
Peanut (53)
People (65511)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22814)
Phase II (32086)
Phase III (24149)
Pipeline (1575)
Policy (204)
Postmarket research (3552)
Preclinical (10291)
Press Release (72)
Prostate cancer (135)
Psychedelics (39)
Radiopharmaceuticals (275)
Rare diseases (479)
Real estate (7397)
Recruiting (75)
Regulatory (26946)
Reports (61)
Research institute (2663)
Resumes & cover letters (649)
Rett syndrome (9)
RNA editing (9)
RSV (52)
Schizophrenia (90)
Series A (156)
Series B (105)
Service/supplier (30)
Sickle cell disease (62)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4297)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (62)
The Weekly (87)
Vaccines (855)
Venture capitalists (49)
Weight loss (311)
Women's health (45)
Worklife (20)
Date
Today (130)
Last 7 days (757)
Last 30 days (3554)
Last 365 days (34927)
2025 (15657)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (66)
Alaska (7)
Arizona (277)
Arkansas (14)
Asia (50348)
Australia (8852)
California (7303)
Canada (2264)
China (651)
Colorado (311)
Connecticut (325)
Delaware (184)
Europe (115518)
Florida (1071)
Georgia (248)
Hawaii (1)
Idaho (65)
Illinois (700)
India (31)
Indiana (365)
Iowa (16)
Japan (209)
Kansas (115)
Kentucky (30)
Louisiana (17)
Maine (73)
Maryland (1050)
Massachusetts (5588)
Michigan (265)
Minnesota (455)
Mississippi (3)
Missouri (95)
Montana (32)
Nebraska (26)
Nevada (77)
New Hampshire (72)
New Jersey (2030)
New Mexico (31)
New York (2042)
North Carolina (1201)
North Dakota (10)
Northern California (3155)
Ohio (242)
Oklahoma (16)
Oregon (48)
Pennsylvania (1567)
Puerto Rico (17)
Rhode Island (39)
South America (1653)
South Carolina (32)
South Dakota (1)
Southern California (2691)
Tennessee (119)
Texas (1098)
United States (27623)
Utah (215)
Virginia (194)
Washington D.C. (78)
Washington State (653)
West Virginia (4)
Wisconsin (80)
There are 850,118 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment
June 5, 2025
·
5 min read
Autoimmune disease
Cullinan Bets $700M+ in Back-Heavy China Deal for Autoimmune T Cell Engager
Genrix’s velinotamig complements Cullinan’s own pipeline, according to William Blair, which added that the deal will put Cullinan in a better position to target autoimmune diseases.
June 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Kailera Therapeutics Appoints Adam Koppel and Christopher Hite to Board of Directors
June 5, 2025
·
3 min read
Press Releases
Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®
June 5, 2025
·
5 min read
Press Releases
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
June 5, 2025
·
10 min read
Press Releases
Dyne Therapeutics to Present New Preclinical Data in Facioscapulohumeral Muscular Dystrophy at the FSHD Society International Research Congress
June 5, 2025
·
5 min read
Press Releases
Simulations Plus Releases ADMET Predictor® 13
June 5, 2025
·
4 min read
Press Releases
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
June 5, 2025
·
4 min read
Layoff Tracker
Rapt Shrinks Again After Dumping Asthma, Atopic Dermatitis Drug
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
June 5, 2025
·
219 min read
·
BioSpace Editorial Staff
Press Releases
The Joint Corp. Announces $5 Million Stock Repurchase Program
June 5, 2025
·
5 min read
1 of 85,012
Next
